The International Vaccine Institute (IVI), based in South Korea, has disclosed that it was set to begin Covid-19 vaccine trials in a hospital in the country.
“Our Phase I/II clinical trial of @InovioPharma’s COVID-19 vaccine is officially underway in Korea at the Seoul National University Hospital.
“Thank you to the volunteers and our partners @CEPIvaccines and the Korea NIH!,” it tweeted on Friday.
Recall that the World Health Organization (WHO) had maintained that a vaccine was greatly needed if the Coronavirus pandemic would be curbed decisively.
As such, many countries are currently embarking on the trial, with institutes in China, United Kingdom, Russia and the United States of America, all entering their final phases.
The SARs-like virus which sprang up from Wuhan China, in late December 2019, has at the moment, infected over 13 million people.
The public health advisory by WHO has remained wearing of facemask, washing of hands, social distancing, among others.